MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/10600280231206130

Медицинская библиотека · The Annals of pharmacotherapy · 2023

Evaluation of Newly Integrated Bivalirudin Titration Protocol in Patients With Mechanical Circulatory Support.

Mitchell Madeline, Sullinger Danine, Dyer Duke, Hickey Gavin, Kaczorowski David, Minor Joni, Murray Holt, Ramanan Raj, Rhinehart Zachary, Schmidhofer Mark, Rivosecchi Ryan M

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Patients with cardiogenic shock or end-stage heart failure can be maintained on mechanical circulatory support (MCS) devices. Once a patient undergoes placement of a device, obtaining and maintaining therapeutic anticoagulation is vital. Guidelines recommend the use of institutional protocols to assist in dosing and titration of anticoagulants.

OBJECTIVE

The purpose of this study was to characterize the use of bivalirudin before and after the implementation of a standardized titration protocol in patients with MCS.

METHODS

A retrospective review of patients who received bivalirudin for MCS (VA ECMO [veno-arterial extracorporeal membrane oxygenation], Impella, or LVAD [left ventricular assist device]) before and after the implementation of the titration protocol into the electronic health record (EHR) was conducted. The primary outcome was to compare the proportion of therapeutic activated partial thromboplastin time (aPTT). Secondary outcomes included number of subtherapeutic and supratherapeutic aPTTs, incidence of bleeding and clotting events, bivalirudin titrations per day, and percentage of patients with therapeutic aPTT level.

RESULTS

A total of 100 patients were included (precohort = 67; postcohort = 33). The proportion of therapeutic aPTTs was significantly higher in the postcohort than that in the precohort (62% vs 48%; P < 0.001). The postcohort had 0% of patients failing to achieve therapeutic aPTT levels. The number of titrations per day was significantly lower in the postcohort, with 1.20 titrations per day versus 1.93 in the precohort (P < 0.001).

CONCLUSIONS

Implementation of the bivalirudin titration nomograms within the EHR significantly increased the number of therapeutic aPTTs, reduced the number of patients who never achieved a therapeutic aPTT, and reduced the required number of titrations per day.

Для цитирования: Mitchell Madeline, Sullinger Danine, Dyer Duke, Hickey Gavin, Kaczorowski David, Minor Joni, Murray Holt, Ramanan Raj, Rhinehart Zachary, Schmidhofer Mark, Rivosecchi Ryan M. Evaluation of Newly Integrated Bivalirudin Titration Protocol in Patients With Mechanical Circulatory Support.. The Annals of pharmacotherapy. 2023. DOI: 10.1177/10600280231206130.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.